Lang, Martin
Schmidt, Laura S.
Wilson, Kelli M.
Ricketts, Christopher J.
Sourbier, Carole
Vocke, Cathy D.
Wei, Darmood
Crooks, Daniel R.
Yang, Youfeng
Gibbs, Benjamin K.
Zhang, Xiaohu
Klumpp-Thomas, Carleen
Chen, Lu
Guha, Rajarshi
Ferrer, Marc
McKnight, Crystal
Itkin, Zina
Wangsa, Darawalee
Wangsa, Danny
James, Amy
Difilippantonio, Simone
Karim, Baktir
Morís, Francisco
Ried, Thomas
Merino, Maria J.
Srinivasan, Ramaprasad
Thomas, Craig J.
Linehan, W. Marston
Funding for this research was provided by:
National Institutes of Health
Article History
Received: 22 December 2022
Accepted: 6 April 2023
First Online: 25 April 2023
Declarations
:
: This study was approved by the Institutional Review Board of the National Cancer Institute and patients provided informed consent on either Urologic Oncology Branch protocol NCI-89-C-0086 or NCI-97-C-0147. Frederick National Laboratory for Cancer Research is accredited by AAALAC International and follows the Public Health Service Policy for the Care and Use of Laboratory Animals. Animal care was provided in accordance with the procedures outlined in the “Guide for the Care and Use of Laboratory Animal<i>s</i>” (National Research Council; 2011; National Academies Press; Washington, DC). All animal studies were approved by the Animal Care and Use Committee of the Frederick National Laboratory for Cancer Research.
: Not applicable.
: The authors declare they have no competing interests. FM is an employee of EntreChem SL, who provided EC-8042.